UN AIDS head urges Gilead to allow generic manufacturing of HIV drug Lenacapavir for global access.
UN AIDS head Winnie Byanyima urges Gilead to make history by allowing generic manufacturing of its new HIV drug, Lenacapavir. The twice-yearly injectable antiretroviral medication could help end the AIDS pandemic if accessible in low- and middle-income nations. Byanyima told AFP that Gilead has the opportunity to save the world from the pandemic and be renowned for conquering it, rather than focusing solely on financial rewards.
July 22, 2024
3 Articles